跳至主要内容
临床试验/NCT04807621
NCT04807621Unknown2 期

Platelets or Fibrinogen as First-line Treatment for Bleeding During Pedatric Heart Surgery: a Randomized, Controlled Trial.

Sahlgrenska University Hospital, Sweden1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2018年3月14日最近更新:
适应症

试验速览

阶段
2 期
发起方
入组人数
40
试验地点
1
主要终点
HEPTEM-A10

研究概览

简要总结

The study aims to test whether platelet transfusion or fibrinogen concentrate is the most effective treatment of intraoperative bleeding, when performing open heart surgery with cardiopulmonary bypass on children with congenital heart defects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
— 至 12 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Children < 1 years of age, scheduled for open surgery of congenital heart defects, using cardiopulmonary bypass.
  • Body weight < 10 kg.
  • Expected CPB time > 90 minutes.

排除标准

  • Known coagulation disorder, current treatment with antiplatelet and/or anticoagulant drugs, major surgery the past month before the planned surgery, preoperative kidney or liver failure (defined as creatinine and/or transaminases > normal interval for the patient´s age), gestational age < 34 weeks.

结局指标

主要结局

HEPTEM-A10

时间窗: 45 minutes after intervention

The outcome measure is a measure of global coagulation efficacy, obtained by ROTEM analysis.

次要结局

  • Amount of transfused packed red blood cells(up to first postoperative morning)

研究者

发起方
Sahlgrenska University Hospital, Sweden
申办方类型
Other
责任方
Principal Investigator
主要研究者

Fredrik Söderlund

Consultant, Anaesthesia and Intensive Care

Sahlgrenska University Hospital, Sweden

研究点 (1)

Loading locations...

相似试验